Unicycive Therapeutics, Inc. UNCY

Full chart Compare
Set alert

Price alert · UNCY

All alert types
3.70 USD +0.11 (+3.06%)

Nov 4, 2026, 12:22 PM EST

3.63 Day range 3.79
3.33 52-week range 8.74
YTD
-35.88%
1 year
-16.67%

Revenue & Expenses

Revenue → Gross Profit: $675.00KGross Profit → Expenses: $675.00KExpenses → Selling, General & Admin: $8.55MExpenses → Research & Development: $12.90MExpenses → Interest Expense: $82.00KExpenses → Other Expenses: $9.69MNet Loss → Expenses: $30.54MGross Profit$675.00KNet Loss$30.54MExpenses$31.22MSelling, General & Admin$8.55MResearch & Development$12.90MInterest Expense$82.00KOther Expenses$9.69MRevenue$675.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

UNCY annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-29.52M-32.12M-21.45M-19.00M-8.98M
-26.55M-36.73M-30.54M-18.06M-10.02M
-1.67-5.65-12.80-12.00-8.60
UNCY annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
29.20M26.14M9.70M455.00K16.58M
49.13M31.67M14.19M2.82M18.74M
18.94M24.24M18.00M3.28M2.26M
117.00K681.00K793.00K155.00K306.00K
30.20M7.43M-3.81M-466.00K16.48M
UNCY annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-31.32M-28.57M-18.28M-15.65M-5.77M
-12.10M-72.00K-12.00K-2.00K-29.00K
46.47M45.09M27.54M-471.00K22.38M
-24.00K-72.00K-12.00K-2.00K-29.00K
3.06M16.44M9.25M-16.12M16.58M